WO2000007627A3 - Topical delivery systems for active agents - Google Patents

Topical delivery systems for active agents Download PDF

Info

Publication number
WO2000007627A3
WO2000007627A3 PCT/US1999/017387 US9917387W WO0007627A3 WO 2000007627 A3 WO2000007627 A3 WO 2000007627A3 US 9917387 W US9917387 W US 9917387W WO 0007627 A3 WO0007627 A3 WO 0007627A3
Authority
WO
WIPO (PCT)
Prior art keywords
agents
active agents
delivery systems
topical delivery
hair
Prior art date
Application number
PCT/US1999/017387
Other languages
French (fr)
Other versions
WO2000007627A8 (en
WO2000007627A2 (en
Inventor
Susan M Niemiec
Jonas C T Wang
Stephen J Wisniewski
Kurt S Stenn
Gwang Wei Lu
Original Assignee
Johnson & Johnson Consumer
Susan M Niemiec
Jonas C T Wang
Stephen J Wisniewski
Kurt S Stenn
Gwang Wei Lu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer, Susan M Niemiec, Jonas C T Wang, Stephen J Wisniewski, Kurt S Stenn, Gwang Wei Lu filed Critical Johnson & Johnson Consumer
Priority to AU56695/99A priority Critical patent/AU5669599A/en
Priority to EP99943639A priority patent/EP1104280A2/en
Priority to CA002339231A priority patent/CA2339231A1/en
Priority to JP2000563309A priority patent/JP2003521452A/en
Publication of WO2000007627A2 publication Critical patent/WO2000007627A2/en
Publication of WO2000007627A3 publication Critical patent/WO2000007627A3/en
Publication of WO2000007627A8 publication Critical patent/WO2000007627A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0291—Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Abstract

This invention relates to a method for enhancing the transmembrane penetration of benefit agents using a certain non-ionic lipid/surfactant-containing formulation as an enhancing agent, and the compositions used therein. Various active agents, such as anti-dandruff agents, hair growth agents, hair inhibitor agents, anti-acne agents, anti-aging agents, depilatory agents, and depigmentation agents, may be effectively delivered into the skin, hair follicles and sebaceous glands using the compositions of the present invention.
PCT/US1999/017387 1998-08-04 1999-08-02 Topical delivery systems for active agents WO2000007627A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU56695/99A AU5669599A (en) 1998-08-04 1999-08-02 Topical delivery systems for active agents
EP99943639A EP1104280A2 (en) 1998-08-04 1999-08-02 Topical delivery systems for active agents
CA002339231A CA2339231A1 (en) 1998-08-04 1999-08-02 Topical delivery systems for active agents
JP2000563309A JP2003521452A (en) 1998-08-04 1999-08-02 Local delivery system for active agents

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9528998P 1998-08-04 1998-08-04
US60/095,289 1998-08-04
US09/360,412 1999-07-23
US09/360,412 US6284234B1 (en) 1998-08-04 1999-07-23 Topical delivery systems for active agents

Publications (3)

Publication Number Publication Date
WO2000007627A2 WO2000007627A2 (en) 2000-02-17
WO2000007627A3 true WO2000007627A3 (en) 2000-08-17
WO2000007627A8 WO2000007627A8 (en) 2001-02-08

Family

ID=26790038

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/017387 WO2000007627A2 (en) 1998-08-04 1999-08-02 Topical delivery systems for active agents

Country Status (10)

Country Link
US (2) US6284234B1 (en)
EP (1) EP1104280A2 (en)
JP (1) JP2003521452A (en)
CN (1) CN1303263A (en)
AR (1) AR019997A1 (en)
AU (1) AU5669599A (en)
CA (1) CA2339231A1 (en)
CO (1) CO5080786A1 (en)
TW (1) TWI257310B (en)
WO (1) WO2000007627A2 (en)

Families Citing this family (216)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011834B1 (en) * 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
AUPO983897A0 (en) * 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
PL350917A1 (en) 1999-03-05 2003-02-10 Procter & Gamble C16 unsaturated fp-selective prostaglandins analogs
DE19921794A1 (en) * 1999-05-11 2000-11-23 Hexal Ag New pharmaceutical composition
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
IL132625A (en) * 1999-10-28 2007-06-17 Avi Dascalu Composition for inducing hair growth
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
JP4213837B2 (en) * 2000-02-18 2009-01-21 株式会社マンダム Hair restorer composition
US6596266B2 (en) * 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
EP1269972B1 (en) * 2000-04-07 2005-10-19 Taisho Pharmaceutical Co., Ltd Hair growth stimulant compositions with sustained action
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
EP1335719B1 (en) * 2000-05-12 2007-12-19 Meracol Corporation Limited Cetyl myristate and cetyl palmitate for treating eczema and/or psoriasis
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
ATE383855T1 (en) * 2000-05-12 2008-02-15 Meracol Corp Ltd TREATMENT OF IRRITABLE COLON SYNDROME OR DISEASE
US7241731B2 (en) 2000-06-05 2007-07-10 Sumitomo Electric Industries, Ltd. Oligopeptides for promoting hair growth
US20050008602A1 (en) * 2000-06-05 2005-01-13 Sumitomo Electric Industries, Ltd. Oligopeptides for promoting hair growth
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
FR2812192B1 (en) * 2000-07-28 2003-01-31 Oreal USE OF PROSTAGLANDIN EP-3 RECEPTOR ANTAGONISTS AS A COSMETIC AGENT FOR MITIGATING, REDUCING OR STOPPING HAIR AND HAIR LOSS
FR2812190B1 (en) * 2000-07-28 2003-01-31 Oreal USE OF NON-PROSTANOIC AGONISTS OF EP-2 AND / OR EP-4 PROSTAGLANDIN RECEPTORS AS A COSMETIC AGENT FOR MITIGATING, DECREASING OR STOPPING HAIR AND HAIR LOSS
FR2812191B1 (en) * 2000-07-28 2003-10-17 Oreal USE OF PROSTAGLANDIN E2 RECEPTOR AGONISTS (EP-3) TO ATTENUATE, DECREASE OR STOP HAIR AND HAIR GROWTH IN COSMETIC PREPARATIONS
FR2812193B1 (en) * 2000-07-28 2003-10-24 Oreal USE OF AN ANTAGONIST OF PROSTAGLANDIN EP-2 AND / OR EP-4 RECEPTORS TO ATTENUATE, DECREASE OR STOP HAIR AND HAIR GROWTH IN COSMETIC PREPARATIONS
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
WO2002011768A1 (en) 2000-08-03 2002-02-14 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7442369B1 (en) 2000-08-09 2008-10-28 Mcneil Ab Compositions of minoxidil
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
EP1265595B1 (en) 2000-09-08 2005-06-08 Vivier Canada Inc. Stabilized ascorbic acid solutions
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation
US20040067245A1 (en) * 2000-12-20 2004-04-08 Harish Mahalingam Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
KR100423666B1 (en) * 2001-02-07 2004-03-18 보령제약 주식회사 Composition of Antifungal Topical preparations
JP2003012468A (en) * 2001-06-28 2003-01-15 Kaminomoto Co Ltd Promoter for restoration and growth of hair
DE60228713D1 (en) * 2001-07-18 2008-10-16 Unilever Nv COMPOSITIONS FOR THE TREATMENT OF HAIR AND / OR HEADACHE
US6866841B2 (en) 2001-08-09 2005-03-15 Epatentmanager.Com Non-endocrine disrupting cytoprotective UV radiation resistant substance
US7261878B2 (en) * 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
US20070238697A1 (en) * 2001-08-29 2007-10-11 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
JP2005508997A (en) * 2001-09-28 2005-04-07 エルジー ハウスホールド アンド ヘルス ケア エルティーディー． Hair growth promoter composition
US7625574B2 (en) * 2001-09-28 2009-12-01 Shiseido Research Center Skin treatment composition
JP2003113023A (en) * 2001-09-28 2003-04-18 Shiseido Co Ltd Base for skin care preparation and cosmetic formulated with the same
SE0104421D0 (en) 2001-12-21 2001-12-21 Ponsus Pharma Ab New composition
US7160921B2 (en) * 2002-01-29 2007-01-09 The Gillette Company Reduction of hair growth
US20040198821A1 (en) * 2002-01-29 2004-10-07 Hwang Cheng Shine Reduction of hair growth
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
US7241808B2 (en) * 2002-05-01 2007-07-10 Marvin Klein Composition for treatment of skin and method for stabilizing the composition
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
SI21258A (en) 2002-07-17 2004-02-29 LEK farmacevtska dru�ba d.d. Stable pharmaceutical preparation containing erythropoietin and poloxamer polyol
DE10240029A1 (en) * 2002-08-27 2004-03-11 Beiersdorf Ag Synergistic antimycotic combinations of climbazole, piroctone olamine and undecyleneamidopropyl betaine, useful for combating seborrheic disorders, especially dandruff
US8900607B1 (en) 2002-09-25 2014-12-02 Chemsil Silicones, Inc. Clear, greaseless skin-care compositions
US20040086471A1 (en) * 2002-10-31 2004-05-06 Lin Connie Baozhen Compositions for darkening the skin and/or hair
US7939489B2 (en) * 2002-12-23 2011-05-10 Avon Products, Inc. Oil absorbent topical compositions and methods for using same
US20040141935A1 (en) * 2003-01-21 2004-07-22 Peter Styczynski Reduction of hair growth
MXPA05007722A (en) * 2003-01-24 2006-01-31 Connetics Australia Pty Ltd Clindamycin phosphate foam.
US20060115522A1 (en) * 2003-02-17 2006-06-01 Cipla Ltd Pharmaceutical composition
US7015349B2 (en) 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20050037046A1 (en) * 2003-07-31 2005-02-17 Ken Braun Fish attractant and applicator
WO2005025522A2 (en) * 2003-09-10 2005-03-24 The Procter & Gamble Company Skin care composition
AU2004283431B2 (en) 2003-10-10 2009-09-10 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
FR2863174B1 (en) * 2003-12-08 2006-11-24 Galderma Res & Dev DEVICE FOR DETERMINING A PRODUCT INTENDED TO BE APPLIED ON THE SKIN
US20050127552A1 (en) * 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Method for forming an elastomeric article
US20050132466A1 (en) * 2003-12-11 2005-06-23 Kimberly-Clark Worldwide, Inc. Elastomeric glove coating
US7935331B2 (en) * 2003-12-12 2011-05-03 Johnson & Johnson Consumer Companies, Inc. Vanillin polymers for use in darkening the skin
US20050136015A1 (en) * 2003-12-17 2005-06-23 McKie Derrick B. Topical use of halosalicylic acid derivatives
US20070086977A1 (en) * 2003-12-22 2007-04-19 Stockel Richard F Method of treating dermatological conditions
US20050163811A1 (en) * 2004-01-23 2005-07-28 Richard Lee Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof
DE102004004509B4 (en) * 2004-01-23 2010-07-01 Epoplus Gmbh Co.Kg Use of low dose erythropoietin to stimulate endothelial progenitor cells as well as organ regeneration and progression slowing of end organ damage
US20050196371A1 (en) * 2004-03-08 2005-09-08 L'oreal Aqueous composition based on alcohol, surfactant and solubilizing agent, article impregnated with this composition, and method for cleansing the hair
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US8158139B2 (en) * 2004-07-12 2012-04-17 Taro Pharmaceuticals North America, Inc. Topical gel formulation comprising organophosphate insecticide and preparation thereof
WO2006017263A1 (en) * 2004-07-12 2006-02-16 Taro Pharmaceutical Industries Ltd. Topical gel formulation comprising organophosphate insecticide and its preparation thereof
US20060121073A1 (en) * 2004-07-12 2006-06-08 Sandhya Goyal Topical gel formulation comprising insecticide and its preparation thereof
CN1988880A (en) * 2004-07-23 2007-06-27 宝洁公司 Skin care composition containing a flavonoid and vitamin b3
EP1773287A1 (en) * 2004-07-23 2007-04-18 The Procter and Gamble Company Substrate based skin care device
JP2008507524A (en) * 2004-07-23 2008-03-13 ザ プロクター アンド ギャンブル カンパニー Skin care composition containing flavonoids and vitamin B3
US20060018861A1 (en) * 2004-07-23 2006-01-26 Minghua Chen Skin care composition
US20060034779A1 (en) * 2004-08-02 2006-02-16 Agis Industries (1983) Ltd. Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
ES2729826T3 (en) * 2004-09-23 2019-11-06 Arc Medical Devices Inc Pharmaceutical compositions and related methods to inhibit fibrous adhesions or inflammatory disease using low sulfate fucans
US7423064B2 (en) * 2004-09-24 2008-09-09 Olatec Industries, Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
JP2008519764A (en) * 2004-11-09 2008-06-12 イマジナティブ リサーチ アソシエィツ インコーポレーテッド Retinoid solutions and formulations made from them
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
WO2006058430A1 (en) * 2004-12-02 2006-06-08 Testa Hair Holdings Inc. Composition for treating hair and scalp and method for preparing same
MX2007007624A (en) * 2004-12-22 2007-08-03 Gillette Co Reduction of hair growth with survivin inhibitors.
BRPI0519216A2 (en) * 2004-12-22 2009-01-06 Gillette Co hair growth reduction
US20070032781A1 (en) * 2004-12-22 2007-02-08 Henry James P Reduction of hair growth
US20060177392A1 (en) * 2005-02-10 2006-08-10 William Walden Oil-based composition for acne
JP2008533037A (en) * 2005-03-10 2008-08-21 ジェイアール ケム エルエルシー Benzoyl peroxide composition and method of use
US7390431B2 (en) * 2005-03-10 2008-06-24 Jr Chem, Llc Stable organic peroxide compositions
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
EP1709996A1 (en) * 2005-04-07 2006-10-11 L'oreal Aqueous composition based on alcohol, surfactant and solubilizing agent, article impregnated with said composition and hair cleaning process
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
NZ563270A (en) 2005-05-10 2010-11-26 Dermipsor Ltd Calcipotriol, polyethylene oxide topical compositions for the treatment of hyperproliferative epidermal diseases
JP2008540513A (en) * 2005-05-10 2008-11-20 ダーミプソル リミテッド Compositions and methods for skin care
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
CN103948927B (en) 2005-06-17 2017-11-07 威斯康星校友研究基金会 The topical vasoconstrictor preparations and method of cell are protected in cancer chemotherapy and radiotherapy
AR054805A1 (en) * 2005-06-29 2007-07-18 Stiefel Laboratories TOPICAL COMPOSITIONS FOR SKIN TREATMENT
WO2007005471A2 (en) * 2005-06-29 2007-01-11 Jr Chem, Llc Stable organic peroxide compositions
US7556820B2 (en) 2005-06-29 2009-07-07 Jr Chem, Llc Stable organic peroxide compositions
US20090306023A1 (en) * 2005-06-29 2009-12-10 Ramirez Jose E Stable organic peroxide compositions
US20070044810A1 (en) * 2005-06-29 2007-03-01 Jr Chem, Llc Method of enhanced drug application
WO2007005469A2 (en) * 2005-06-29 2007-01-11 Jr Chem, Llc Method of enhanced benzoyl peroxide application
US7560445B2 (en) 2005-07-06 2009-07-14 Taro Pharmaceuticals North America, Inc. Process for preparing malathion for pharmaceutical use
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
WO2007023841A1 (en) * 2005-08-25 2007-03-01 Taisho Pharmaceutical Co., Ltd. Hair growth agent composition
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
TR201815853T4 (en) 2005-10-12 2018-11-21 Besins Healthcare Sarl Testosterone gel for use in the treatment of hypogonadism.
FR2892929B1 (en) * 2005-11-09 2012-04-27 Oreal COSMETIC COMPOSITION COMPRISING A FATTY-STRUCTURING SILICONE POLYMER CHARACTERIZED BY HARDNESS
FR2892930B1 (en) * 2005-11-09 2012-03-09 Oreal COSMETIC COMPOSITION COMPRISING A STRUCTURING SILICONE POLYMER OF A FATTY PHASE CHARACTERIZED BY VISCOSITY
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
US9107844B2 (en) * 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
CA2645073A1 (en) * 2006-03-08 2007-09-13 Nuviance, Inc. Transdermal drug delivery compositions and topical compositions for application on the skin
PL2206494T3 (en) 2006-03-31 2016-06-30 Stiefel Res Australia Pty Ltd Foamable suspension gel
US8399012B2 (en) * 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
US8703179B2 (en) * 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
ES2385875T3 (en) 2006-05-19 2012-08-02 Mary Kay, Inc. Compositions comprising glyceryl salicylate compounds
WO2007142942A2 (en) * 2006-05-30 2007-12-13 Den-Mat Holdings Llc Method of improving wound healing
MX2008015266A (en) * 2006-06-01 2009-02-10 Nobera Pharma Sl Use of allopurinol for the treatment of palmar plantar erythrodysesthesia.
US20080059313A1 (en) * 2006-08-30 2008-03-06 Oblong John E Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
US20080099168A1 (en) * 2006-10-26 2008-05-01 Kou-Chang Liu Soft and absorbent tissue products
WO2008082525A1 (en) * 2006-12-19 2008-07-10 National Stem Cell Inc Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
US20080219939A1 (en) * 2007-03-07 2008-09-11 Grune Guerry L Sunblock formulations
US20080241085A1 (en) 2007-03-29 2008-10-02 Lin Connie B Compositions for use in darkening the skin
FR2915097B1 (en) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique ANTIFUNGAL FOAM BASED ON CICLOPIROXOLAMINE AND ZINC PYRITHIONE AND ITS MEDICAL AND COSMETIC APPLICATIONS.
KR101527829B1 (en) 2007-04-19 2015-06-12 마리 케이 인코포레이티드 Magnolia extract containing compositions
JP2010524648A (en) * 2007-04-23 2010-07-22 トランスダーマル キャップ インコーポレイテッド Phototherapy light cap
WO2008150300A1 (en) * 2007-05-21 2008-12-11 Sergeant's Pet Care Products Pest control formulation
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
WO2009032907A2 (en) * 2007-09-04 2009-03-12 Quinnova Pharmaceuticals, Inc. Stay-on selenium foam
US20090087395A1 (en) 2007-10-01 2009-04-02 Lin Connie B Compositions for use in darkening the skin
AU2008310670A1 (en) * 2007-10-11 2009-04-16 Mcneil-Ppc, Inc. Improved topical pain relief product
RU2508133C2 (en) * 2008-04-21 2014-02-27 МакНЕЙЛ-ППС, ИНК. Local delivery system comprising two aerosol chambers
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
NZ590950A (en) * 2008-07-18 2012-12-21 Biomod Concepts Inc Articles of manufacture releasing an active ingredient
PT2344198T (en) * 2008-09-27 2020-12-04 Jina Pharmaceuticals Inc Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
RU2011120054A (en) * 2008-10-21 2012-11-27 Новодермикс Интернэшнл Лимитед COMPOSITIONS FOR TREATMENT OF EPITELIAL TISSUE
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US20150374600A1 (en) * 2009-02-11 2015-12-31 Joseph F. Walsh Methods and preparations that treat human hair loss
US20100209368A1 (en) * 2009-02-11 2010-08-19 Walsh Joseph F Method and preparation for treating baldness
US20100242155A1 (en) * 2009-03-25 2010-09-30 Carullo Jr John F Headgear equipped with laser hair care apparatus
BRPI1006678B1 (en) 2009-04-23 2017-02-21 Unilever Nv "hair treatment composition"
WO2010121919A1 (en) * 2009-04-23 2010-10-28 Unilever Plc Hair care composition comprising trichogen complex and an azole
EP2246057A1 (en) * 2009-04-29 2010-11-03 Nobera Pharma, S.L. Use of allopurinol for the treatment of hand foot skin reaction
US8470304B2 (en) 2009-08-04 2013-06-25 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
EP3141246A1 (en) 2009-08-31 2017-03-15 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20110076312A1 (en) * 2009-09-29 2011-03-31 Ethicon, Inc. Antimicrobial/antibacterial medical devices coated with traditional chinese medicines
US8470880B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
US20120003300A1 (en) * 2010-06-30 2012-01-05 Pangaea Laboratories Ltd Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss
US20120064135A1 (en) * 2010-09-15 2012-03-15 Norac Pharma Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
EP2438908A1 (en) 2010-10-11 2012-04-11 Vectum Pharma, S.L. Anchoring compositions for topical applications
US20120128753A1 (en) * 2010-11-18 2012-05-24 Sally Villalobos Meditowel pre-packaged medicated muscle and joint pain relief wipe
CA2932130C (en) 2011-01-07 2019-07-09 Allergan, Inc. Compositions comprising substituted benzaldehydes and use thereof for lightening skin or treating hyperpigmenation and hypermelanosis disorders
JP5934781B2 (en) * 2011-04-25 2016-06-15 パーク、ジュン−ヒョン External preparation composition for preventing hair loss and promoting hair growth
EA032840B8 (en) 2011-06-22 2020-06-18 Вайоми Терапеутикс Лимитед Conjugate-based antifungal prodrugs and use thereof
FR2992859B1 (en) * 2012-07-09 2014-10-03 Fabre Pierre Dermo Cosmetique USE OF COCETH ZINC SULFATE AS ANTIBACTERIAL AGENT AFTER PROPIONIBACTERIUM ACNES
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
BR102012022036B1 (en) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. FINASTERIDE AND MINOXIDIL POLYMERIC NANOParticle, PROCESS OF PREPARATION, WATER-CONTAINING SUSPENSION, PHARMACEUTICAL COMPOSITION, AND ITS USE
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US9089131B2 (en) 2013-03-12 2015-07-28 Mary Kay Inc. Preservative system
TWI522102B (en) 2013-04-30 2016-02-21 長庚醫療財團法人 Use of composition for manufacturing drugs for treating or prophylactically treating acne
WO2014184173A1 (en) * 2013-05-14 2014-11-20 Montero Gida Sanayi Ve Ticaret A.S. Hair care formulations
MX2015016675A (en) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Coated particles and compositions comprising same.
US9011934B2 (en) * 2013-06-14 2015-04-21 SatisPharma, LLC Multi-purpose anti-itch treatment
EP2829303A1 (en) * 2013-07-22 2015-01-28 Johnson & Johnson Consumer Companies Inc. Compositions comprising extract of malva neglecta and method of treating a skin condition with malva neglecta
CN105517531A (en) 2013-09-05 2016-04-20 宝洁公司 Scalp care composition
CA2933367A1 (en) * 2013-12-13 2015-06-18 Restorsea, Llc Exfoliative hair retention-promoting formulation
US9522189B2 (en) 2013-12-20 2016-12-20 Johnson & Johnson Consumer Inc. Topical gel compositions including poly(monostearoyl glycerol-co-succinate) polymer and methods for enhancing the topical application of a benefit agent
US20150174254A1 (en) 2013-12-23 2015-06-25 Mcneil-Ppc, Inc. Topical gel compositions including polycaprolactone polymer and methods for enhancing the topical application of a benefit agent
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US9474699B2 (en) 2014-03-31 2016-10-25 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of a basic benefit agent
US9468606B2 (en) 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
US9549885B2 (en) 2014-04-24 2017-01-24 The Procter & Gamble Company Scalp care composition
AU2015259509A1 (en) 2014-05-16 2016-11-24 Restorsea, Llc Biphasic cosmetic
US11696883B2 (en) 2014-05-23 2023-07-11 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
US10470992B2 (en) 2014-05-23 2019-11-12 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
CA2950313A1 (en) 2014-06-16 2015-12-23 Johnson & Johnson Consumer Inc. Compositions and methods for enhancing the topical application of a color cosmetic
WO2015195304A1 (en) 2014-06-17 2015-12-23 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for enhancing the topical application of a benefit agent including powder to liquid particles and a second powder
US9675537B2 (en) 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
US9452178B1 (en) 2014-10-22 2016-09-27 SatisPharma, LLC Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations
IL301676A (en) 2014-10-24 2023-05-01 Garuhda Llc Combined hair loss inhibition treatment
EP4349414A2 (en) 2014-12-23 2024-04-10 Dyve Biosciences, Inc. Methods and formulations for transdermal administration
US9351945B1 (en) * 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
PL3347009T3 (en) 2015-07-08 2022-02-07 Triple Hair Inc. Composition comprising resveratrol and melatonin for reducing hair loss and/or increasing hair regrowth
US10130578B2 (en) * 2015-07-23 2018-11-20 Johnson & Johnson Consumer Inc. Topical delivery of skin compositions having low pH
BR112018005643A8 (en) * 2015-09-22 2022-08-09 Johnson & Johnson Consumer Inc METHODS TO IMPROVE THE TOPICAL APPLICATION OF A BASIC BENEFIT AGENT
JP2017078044A (en) * 2015-10-21 2017-04-27 大正製薬株式会社 Hair Restorer Composition
US11666520B2 (en) 2015-12-28 2023-06-06 Johnson & Johnson Consumer Inc. Hair growth composition and method
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
KR102345154B1 (en) 2016-12-23 2021-12-29 알.피.쉐러 테크놀러지즈 엘엘씨 Multi-Filled/Chamber Softgel Dies
WO2018206077A1 (en) * 2017-05-08 2018-11-15 Merz Pharma Gmbh & Co. Kgaa Emulsion comprising finasteride
CN107281185B (en) * 2017-06-16 2018-08-17 曹凡 A kind of trichogenous emulsification composition and preparation method thereof
EP3418365A1 (en) 2017-06-19 2018-12-26 The Procter & Gamble Company Automatic dishwashing cleaning composition
WO2019070142A2 (en) * 2017-10-08 2019-04-11 Qatar Pharma For Pharmaceuticals Industries Topical lotion for hair loss treatment (biohair®)
EP3709955A1 (en) * 2017-11-16 2020-09-23 DSM IP Assets B.V. Topical compositions
JP2019210268A (en) * 2018-05-30 2019-12-12 ダイヤ製薬株式会社 External preparation and method for producing external preparation
CN110604741A (en) * 2018-06-15 2019-12-24 瑞恩生化科技有限公司 Composition for inhibiting skin cell proliferation and application thereof
CN108743422A (en) * 2018-06-27 2018-11-06 天津静瀛高新科技有限公司 Broad-spectrum sterilization type shampoo and its manufacturing method
US10463596B1 (en) 2018-06-28 2019-11-05 The Procter And Gamble Company Scalp care composition with well dispersed particulate scalp benefit agents
CA3201012A1 (en) 2020-12-07 2022-06-16 Shantilal H. Modha Damp hand donning and moisturizing glove
CN115475168B (en) * 2022-10-18 2024-02-13 湖北工业大学 Minoxidil-containing pharmaceutical composition and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001863A1 (en) * 1986-09-12 1988-03-24 The Upjohn Company Foams for delivery of minoxidil
EP0431942A2 (en) * 1989-12-06 1991-06-12 Sansho Co., Ltd. Percutaneously absorbable pharmaceutical preparation containing dopamine derivative
WO1992010231A1 (en) * 1990-12-11 1992-06-25 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
WO1994021262A1 (en) * 1993-03-17 1994-09-29 Alza Corporation Device for the transdermal administration of alprazolam
JPH0971513A (en) * 1995-09-07 1997-03-18 Taisho Pharmaceut Co Ltd Hair tonic

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596812A (en) 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
WO1992003123A1 (en) * 1990-08-28 1992-03-05 Liposome Technology, Inc. Liposome alternative bilayer formulations
JPH069394A (en) * 1992-06-25 1994-01-18 Lion Corp External antiphlogistic sedative liquid preparation
DE4330597A1 (en) 1992-10-14 1995-03-16 Ahmad Khalil Hair tonic system and hair lotion for hair loss
JPH072677A (en) 1993-06-18 1995-01-06 Toyo Seito Kk Peroral hair-growing agent
JP3520936B2 (en) * 1993-12-07 2004-04-19 大正製薬株式会社 Hair restorer
JPH07233088A (en) * 1993-12-27 1995-09-05 Takeda Chem Ind Ltd External agent for topical application
US5629021A (en) * 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
JPH0948740A (en) * 1995-08-04 1997-02-18 Pola Chem Ind Inc Selective medicine absorption promoter
JPH0987148A (en) * 1995-09-21 1997-03-31 Suntory Ltd Hair growing composition
JPH09268123A (en) * 1996-03-30 1997-10-14 Nichiban Co Ltd Cataplasm for local anesthesia
JPH09278651A (en) * 1996-04-05 1997-10-28 Sekisui Chem Co Ltd Percutaneous strap
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001863A1 (en) * 1986-09-12 1988-03-24 The Upjohn Company Foams for delivery of minoxidil
EP0431942A2 (en) * 1989-12-06 1991-06-12 Sansho Co., Ltd. Percutaneously absorbable pharmaceutical preparation containing dopamine derivative
WO1992010231A1 (en) * 1990-12-11 1992-06-25 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
WO1994021262A1 (en) * 1993-03-17 1994-09-29 Alza Corporation Device for the transdermal administration of alprazolam
JPH0971513A (en) * 1995-09-07 1997-03-18 Taisho Pharmaceut Co Ltd Hair tonic

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199721, Derwent World Patents Index; Class B05, AN 1997-231136, XP002131769 *

Also Published As

Publication number Publication date
JP2003521452A (en) 2003-07-15
WO2000007627A8 (en) 2001-02-08
CA2339231A1 (en) 2000-02-17
US6419913B1 (en) 2002-07-16
WO2000007627A2 (en) 2000-02-17
US6284234B1 (en) 2001-09-04
TWI257310B (en) 2006-07-01
AU5669599A (en) 2000-02-28
CN1303263A (en) 2001-07-11
AR019997A1 (en) 2002-03-27
EP1104280A2 (en) 2001-06-06
CO5080786A1 (en) 2001-09-25
US20020048558A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
WO2000007627A3 (en) Topical delivery systems for active agents
EP1060732A3 (en) Novel topical formulations comprising vesicle delivery systems
DK0841899T3 (en) Preparations for topical administration of active ingredients
EP0863740B1 (en) Reduction of hair growth
NZ511773A (en) Compositions and methods for treating hair and skin using aqueous delivery systems
EP0934742A3 (en) High glycerin containing anti-microbial cleansers
ES2160631T3 (en) RETINOID COMPOSITIONS FOR TOPICAL APPLICATION.
AU3956599A (en) Surfactant for use in external preparations for skin and external preparation for skin containing the same
CA2137001A1 (en) Lipids for Epidermal Moisturization and Repair of Barrier Function
HUP9904677A2 (en) Cosmetic composition for skin care
WO1999016412A3 (en) Non-irritating cosmetic and pharmaceutical compositions
RU94045127A (en) Depigmentation composition and method for depigmentation of skin
BR9915008A (en) Shampoo composition, and process for preparing it
EP1004289A3 (en) Cosmetic and skin protective compositions comprising catalase
EP1374831A4 (en) Cosmetics or external preparations for skin
MX2007014754A (en) Composition comprising resveratrol and topical use thereof for reducing human hair growth.
AU3931093A (en) Topical composition for inhibiting hair growth
BR0013968B1 (en) structuring product composition for personal care formulations.
WO2005032498A3 (en) Aqueous composition comprising a polyionic dendritic polymer and an ionic surface active agent
AUPR874601A0 (en) Selective targeting of apoptotic cells
EP1192939A3 (en) Methods for reduction of inflammation and erythema
WO1999013819A3 (en) Composition and method for reducing stinging in skin
MX2021015830A (en) Transdermal penetrant formulations.
US6843983B2 (en) Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae
US6528072B1 (en) Topical composition for skin including witch hazel

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99806702.4

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2339231

Country of ref document: CA

Ref document number: 2339231

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1999943639

Country of ref document: EP

AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 07/2000 UNDER (30) REPLACE "09/363412" BY "09/360412"

WWP Wipo information: published in national office

Ref document number: 1999943639

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999943639

Country of ref document: EP